Biological
tiagabine
tiagabine is a biological therapy with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
20%(1 trials)
Phase Distribution
Ph phase_3
1
17%
Ph phase_1
1
17%
Ph phase_2
3
50%
Phase Distribution
1
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(5)
Detailed Status
Completed5
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 23 (60.0%)
Phase 31 (20.0%)
Trials by Status
active_not_recruiting117%
completed583%
Recent Activity
1 active trials
Showing 5 of 6
completed
Population Pharmacokinetics of Antiepileptic in Pediatrics
NCT03196466
active_not_recruitingphase_3
Treating Schizophrenia by Correcting Abnormal Brain Development
NCT00179465
completedphase_1
Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence
NCT01904487
completedphase_2
Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea
NCT02387710
completedphase_2
Tiagabine for the Treatment of Cocaine Dependence - 1
NCT00086255
Clinical Trials (6)
Showing 6 of 6 trials
NCT03196466
Population Pharmacokinetics of Antiepileptic in Pediatrics
NCT00179465Phase 3
Treating Schizophrenia by Correcting Abnormal Brain Development
NCT01904487Phase 1
Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence
NCT02387710Phase 2
Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea
NCT00086255Phase 2
Tiagabine for the Treatment of Cocaine Dependence - 1
NCT00129298Phase 2
Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6